A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Mannkind Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 142,469 shares of MNKD stock, worth $897,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
142,469
Previous 135,893 4.84%
Holding current value
$897,554
Previous $709,000 26.09%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $32,945 - $44,059
6,576 Added 4.84%
142,469 $894,000
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $3,977 - $5,332
982 Added 0.73%
135,893 $709,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $438,460 - $710,980
134,911 New
134,911 $611,000
Q1 2023

May 15, 2023

SELL
$3.95 - $5.63 $112,496 - $160,342
-28,480 Reduced 19.65%
116,455 $477,000
Q4 2022

Feb 14, 2023

BUY
$3.02 - $5.37 $49,443 - $87,917
16,372 Added 12.73%
144,935 $764,000
Q3 2022

Nov 14, 2022

SELL
$2.99 - $4.35 $105,295 - $153,189
-35,216 Reduced 21.5%
128,563 $397,000
Q2 2022

Aug 15, 2022

BUY
$2.67 - $4.77 $156,595 - $279,760
58,650 Added 55.79%
163,779 $624,000
Q1 2022

May 16, 2022

BUY
$2.62 - $4.45 $91,702 - $155,754
35,001 Added 49.91%
105,129 $387,000
Q4 2021

Feb 14, 2022

BUY
$4.05 - $5.37 $284,018 - $376,587
70,128 New
70,128 $306,000
Q2 2021

Aug 16, 2021

SELL
$3.61 - $5.45 $70,474 - $106,394
-19,522 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$3.14 - $6.14 $23,122 - $45,214
-7,364 Reduced 27.39%
19,522 $77,000
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $48,125 - $108,619
26,886 New
26,886 $84,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.62B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.